Protalix BioTherapeutics, Inc. PLX
Set alert
2.57 USD +0.01 +0.43%
As of Nov 3, 11:35 AM ET
2.57 Day range 2.61
1.65 52-week range 3.19
- YTD
- +42.83%
- 1 year
- +7.57%
- Open
- 2.57
- Prev close
- 2.56
- Mkt cap
- 207.07M
- Vol
- 48.66K
- Avg vol
- 780.72K
- EPS
- 0.23
- P/E
- 11.17
- Div yield
- 0.00%
More statistics
- Low
- 2.57
- High
- 2.61
- Forward P/E
- 2.79
- Beta
- 0.67
- Short ratio
- 22.71
- Inst. own
- 5.20%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.43
- 200-d avg
- 1.21
- 1y target
- 14.00
6M chart
Signals (14)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | May 20, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 6 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
Analyst view
Price target (mean) 14.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 18.21M | +73.6% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 53.39M | -18.5% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 101.44M | +90.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |